Search for Severin Schwan and
    1. July 21, 2016

      Roche chief warns of Brexit impact on UK medical research

      Roche, the Swiss pharmaceutical company, has warned that the UK risks losing its leading role in medical research after...

    2. Fast FT

      July 21, 2016

      Roche H1 earnings beat expectations

      Revenue at Swiss pharmaceutical group Roche grew 5 per cent year-on-year in the first half of 2016, pushing earnings...

    1. Fast FT

      April 19, 2016

      Roche Q1 sales surpass expectations

      It was a good start to 2016 for Roche, as the Swiss pharmaceuticals group beat expectations in the first quarter and...

    2. January 28, 2016

      Roche warns of growing political pressure on drug prices in US

      Pharmaceuticals companies should brace for tough scrutiny on drug pricing ahead of the US presidential election but new...

    3. Fast FT

      January 28, 2016

      Solid result from Roche as sales beat estimates

      Roche came good on its forecast to deliver mid-single digit sales growth as it reported higher-than-expected revenue in...

    4. October 22, 2015

      Roche confident of US returns despite drug pricing furore

      Roche is confident of maintaining strong returns on investment in the US even as drug pricing comes under increasing...

    5. July 23, 2015

      Roche shrugs off copycat drugs threat

      Roche has said it is confident of withstanding the threat from a new class of copycat drugs that are expected to...

    6. January 28, 2015

      Roche confident of regaining lead in cancer drugs race

      Roche has moved to reassure investors over its ability to maintain leadership of the cancer drugs market and defend its...

    7. July 24, 2014

      Roche profit falls as writedown and strong Swiss franc hit group

      Roche posted a 7 per cent fall in net profit in the first half of the year, after the Swiss pharmaceuticals group was...

    8. April 15, 2014

      Roche drug boosts to revenue counteracted by currency’s strength

      Roche’s revenues fell 1 per cent in the first quarter as the strength of the Swiss franc weighed on the pharma group,...

    9. October 17, 2013

      Roche / Novartis: combination therapy

      Winter might be descending on the Alps, but spring is in the air in Basel. The Swiss city, home to Roche and Novartis,...

    10. September 30, 2013

      Roche chief Severin Schwan open to co-operation with Novartis

      Roche’s chief executive has signalled openness to renewed co-operation with counterparts at his Swiss rival Novartis,...

    11. September 30, 2013

      Europe belt tightening will hit pharma, warns Roche chief

      Europe risks squandering its leading position in the global pharmaceuticals industry because of the “short-term” and...

    12. July 25, 2013

      Roche chief Severin Schwan plays down risk of graft scandal in China

      Roche’s chief executive played down the dangers of the corruption scandal that has embroiled GlaxoSmithKline in China...

    13. April 11, 2013

      Roche boosted by blockbuster cancer drugs

      Roche kicked off the pharmaceuticals reporting season on a positive note, posting a 6 per cent increase in revenues and...

    14. January 30, 2013

      Roche boosted by robust US sales

      Roche struck a cautious note on its prospects for the coming year as it posted a 4 per cent rise in sales for 2012,...

    15. October 16, 2012

      Weaker Swiss franc lifts Roche sales

      The weakening Swiss franc has helped Roche to report a 15 per cent rise in third-quarter revenues as the drugmaker...

    16. July 26, 2012

      Restructuring costs Roche SFr1.68bn

      Roche, the Swiss pharmaceutical group, maintained its sales targets for 2012, but took SFr1.68bn ($1.72bn) in...

    17. April 18, 2012

      Roche bid halted by Illumina investors

      Roche, the Swiss drugmaker, said on Wednesday it would let its offer to acquire Illumina expire after shareholders of...

    18. April 12, 2012

      Roche persists with Illumina chase

      Roche on Thursday sent its third letter to Illumina shareholders, repeating its readiness to improve its takeover...

    19. April 7, 2012

      Roche looks at raising bid for Illumina

      Roche, the Swiss drug company, said on Friday it might consider raising its bid to acquire Illumina, the US genetic...

    20. April 2, 2012

      Illumina rejects latest Roche offer

      Roche has reacted angrily to Illumina’s rejection of its improved takeover offer as the rhetoric between the US gene...

    21. March 29, 2012

      Roche / Illumina: time to talk

      Severin Schwan is a determined man. The chief executive of Roche Holding will simply not give up on Illumina....

    22. March 29, 2012

      Roche improves offer for Illumina

      Roche on Thursday made its long-expected improved cash offer for Illumina with a 15 per cent increase to $51 a share,...

    23. March 20, 2012

      Roche in appeal to Illumina investors

      By Andrew Jack in London and Alan Rappeport in New York Roche has stepped up the pressure on Illumina, the US...

    24. February 1, 2012

      Roche steps up Illumina bid as sales hold up

      Roche spotlighted the potential of diagnostics, traditionally the junior of its two divisions, as sales of testing and...

    25. January 28, 2012

      Investors brace for improved offer from Roche

      Roche this week sought to strengthen its ambitions in “targeted medicine” with a hostile $5.7bn bid for Illumina of the...

    26. January 25, 2012

      Roche: bid battle is a gutsy move

      “Screw it, let’s go hostile.” That thought is probably what went through Severin Schwan’s mind last week. The chief...

    27. January 25, 2012

      Pharma groups target specialised deals

      Roche sought to strengthen its position in personalised medicine with a $5.7bn hostile bid early on Wednesday for...

    28. January 25, 2012

      Roche launches $5.7bn bid for US group

      Roche, the Swiss drugmaker, on Wednesday described its $5.7bn hostile offer for Illumina as “full and fair” and said it...

    29. FT Alphaville

      January 25, 2012

      Roche in $5.7bn hostile bid for Illumina

      Roche, the Swiss drugmaker, has made a $5.7bn hostile offer for Illumina, the US diagnostics company, as part of the...

    30. October 13, 2011

      Strong franc weighs on Roche sales

      Roche sales fell 15 per cent in the third quarter, as the pharmaceuticals group became the latest Swiss company to...

    31. September 25, 2011

      Roche to offer discounts to developing nations

      Roche is to set to begin offering substantial discounts in developing countries, marking an important strategic shift...

    32. July 21, 2011

      Avastin problems weigh on Roche

      Roche raised its earnings growth guidance to 10 per cent for the year, despite posting a 5 per cent drop in net income...

    33. February 2, 2011

      Roche lifts earnings but faces challenges

      Roche has joined Novartis and AstraZeneca in proposing higher dividends or share buy-backs to boost investor confidence...

    34. January 18, 2011

      Roche finance chief to exit after 10 years

      Roche, the Swiss pharmaceutical group, on Monday said it would replace Erich Hunziker, its long-standing chief...

    35. November 30, 2010

      Incoming Merck chief to focus on pricing

      The incoming head of Merck has pledged to focus on “demonstrating value” in pricing as he oversees the launch of a...

    36. November 17, 2010

      Roche to slash staff numbers by 6%

      Roche will cut 4,800 jobs – or 6 per cent of its workforce – to save SFr2.4bn ($2.4bn) a year, as the Swiss...

    37. October 25, 2010

      Roche to enter new therapy areas

      Roche is planning a big push to expand its business beyond its historic focus on cancer drugs if results from...

    38. September 3, 2010

      Roche to cut jobs after setbacks for drugs

      Roche on Friday confirmed it would be making significant job cuts to tailor spending to tougher markets, but said...

    Search for Severin Schwan and